GALIMMO And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – GALIMMO (GALIM.PA), SWORD GROUP (SWP.PA), GUERBET (GBT.PA) are the highest payout ratio stocks on this list.

We have gathered information regarding stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. GALIMMO (GALIM.PA)

124.14% Payout Ratio

Galimmo SCA operates as a real estate company in Europe. As of December 31, 2021, it owned and managed 52 shopping malls. Galimmo SCA was formerly known as C&Co SCA and changed its name to Galimmo SCA in September 2016. The company was incorporated in 1902 and is headquartered in Paris, France. Galimmo SCA is a subsidiary of Galimmo Real Estate.

Earnings Per Share

As for profitability, GALIMMO has a trailing twelve months EPS of €0.29.

PE Ratio

GALIMMO has a trailing twelve months price to earnings ratio of 52.41. Meaning, the purchaser of the share is investing €52.41 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.01%.

More news about GALIMMO.

2. SWORD GROUP (SWP.PA)

99.42% Payout Ratio

Sword Group S.E. provides IT and digital transformation services in Europe, the United States, the Oceania, and Asia. The company provides strategic and operational consulting, solution engineering and application development, project ownership support and project management support, infrastructure management and application maintenance for third parties, and resource outsourcing. Its products include Sword Phusion, which capture and manage information in a single, accessible, and reliable form; Sword Tell, a CAD software for watch manufacturers; Sword Venue, a digital collaborative solution with a toolbox to help plan the events; and Sword Aequos that helps to create a flexible and customisable data viewing and search experience. The company serves energy, EPC, chemical, utilities, and manufacturing sector. Sword Group S.E. was founded in 2000 and is headquartered in Windhof, Luxembourg.

Earnings Per Share

As for profitability, SWORD GROUP has a trailing twelve months EPS of €1.71.

PE Ratio

SWORD GROUP has a trailing twelve months price to earnings ratio of 21.14. Meaning, the purchaser of the share is investing €21.14 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.72%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 1.7 and the estimated forward annual dividend yield is 5.52%.

More news about SWORD GROUP.

3. GUERBET (GBT.PA)

85.86% Payout Ratio

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was incorporated in 1926 and is headquartered in Villepinte, France.

Earnings Per Share

As for profitability, GUERBET has a trailing twelve months EPS of €-3.35.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.79%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 775.1M for the twelve trailing months.

Volume

Today’s last reported volume for GUERBET is 2572 which is 79.07% below its average volume of 12289.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 29, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 2.97%.

Yearly Top and Bottom Value

GUERBET’s stock is valued at €17.04 at 16:10 EST, way below its 52-week high of €23.20 and way higher than its 52-week low of €15.28.

More news about GUERBET.

4. GRIEG SEAFOOD (GSF.OL)

37.97% Payout Ratio

Grieg Seafood ASA, through its subsidiaries, operates as a fish farming company in Norway, rest of Europe, the United States, Canada, Asia, and internationally. It engages in the production and sale of Atlantic salmon. The company was founded in 1884 and is headquartered in Bergen, Norway. Grieg Seafood ASA operates as a subsidiary of Grieg Aqua AS.

Earnings Per Share

As for profitability, GRIEG SEAFOOD has a trailing twelve months EPS of kr-3.04.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.47%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 96.7% and positive 391.7% for the next.

More news about GRIEG SEAFOOD.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of €1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

More news about 1.

Leave a Reply

Your email address will not be published. Required fields are marked *